Skip to main content

Regression of Coronary Atherosclerosis by LDL-Apheresis

  • Chapter
Drugs Affecting Lipid Metabolism

Part of the book series: Medical Science Symposia Series ((MSSS,volume 2))

  • 86 Accesses

Abstract

Lowering cholesterol by the treatment with LDL-apheresis using dextran sulfate-cellulose beads affinity column resulted in — regression of coronary atherosclerosis in 38% of the patients including — cases of homozygous familial hypercholesterolemia (FH), 25 cases of heterozygous FH, and — other cases of mild to severe hypercholesterolemia. In heterozygous FH and others, regression took place in — out of 15 cases where plasma cholesterol was reduced more than 120 mg/dl by apheresis treatment, but in only — out of 14 cases, where cholesterol reduction was less than 120 mg/dl. Regression was also observed in — out of — cases of homozygous FH and there was no case with progression in this group.

Plasma cholesterol levels are not available in 1 of 15 patients with unchanged segments.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Thompson, G.R., Lowenthal, R. and Myant, N.B. (1975) ‘Plasma exchange in the management of homozygous familial hypercholesterolemia.’ Lancet, 1, 1208.

    Article  PubMed  CAS  Google Scholar 

  2. Yamamoto A., Yokoyama S., Satani M., Kikkawa, T. and Kishino, B.(1988) ‘Evaluation of selective LDL-removal in the treatment of familial hypercholesterolemia: Double membrane filtration and adsorption system In: K. Widhalm and H. Naito (Eds.), Recent Aspects of Diagnosis and Treatment of Lipoprotein Disorders: Impact on Prevention of Atherosclerotic Diseases.’ Alan R. Liss, Inc., New York, pp.357–366.

    Google Scholar 

  3. Castelli, W.P. (1988) ‘Cholesterol and lipids in the risk of coronary artery disease: The Framingham Heart Study.’ Can. J. Cardiol., 4(suppl A), 5A.

    PubMed  Google Scholar 

  4. Assmann G., Schulte H., Funke H., von Edkardstein A., Schmitz, G. and Robnek, H. (1989) ‘High density lipoproteins and atherosclerosis.’ in: G. Crepaldi, A.M. Gotto, E. Manzato, G. Baggio (Eds.), Atherosclerosis VIII, Excerpta Medica, Amsterdam, pp 341–351.

    Google Scholar 

  5. Tarui, S. for the Study Group on Essential Hyperlipidemia in Japan (sponsored by Ministry of Health and Welfare) (1990) ‘Hyperlipidemia and its complication among Japanese.’ J. Jap. Atherosclerosis Soc, 18, — (in Japanese).

    Google Scholar 

  6. Cashin-Hemphill, L., Mack, W.J., Pogoda, J.M., Sanmarco, M.E., Azen, S.P. and Blankenhorn, D.H. (1990) ‘Beneficial effects of colestipol-niacin on coronary atherosclerosis: — 4-year follow-up.’ JAMA, 264, 3013.

    Article  PubMed  CAS  Google Scholar 

  7. Brown, G., Albers, J.J., Fisher, L.D., Schaefer, S.M., Lin, J.T., Kaplan, C, Zhao, X.Q., Bisson, B.D., Fitzpatrick, V.F. and Dodge, H.T. (1990) ‘Regression of coronary artery disease as — result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B.’ N. Engl. J. Med., 323. 1289.

    Article  PubMed  CAS  Google Scholar 

  8. Kane, J.P., Malloy, M.J., Ports, T.A., Phillips, N.R., Diehl, J.C. and Havel, R.J. (1990) ‘Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens.’ JAMA, 264, 3007.

    Article  PubMed  CAS  Google Scholar 

  9. Yamamoto, A. (1991) ‘Regression of atherosclerosis in humans by lowering serum cholesterol.’ Atherosclerosis 89, 1.

    Article  PubMed  CAS  Google Scholar 

  10. Yokoyama S., Hayashi R., Kikkawa T., Tani N., Takada S., Hatanaka, K. and Yamamoto, A. (1984) ‘Specific adsorbent of apolipoprotein B-containing lipoproteins for plasmapheresis: Characterization and experimental use in hypercholesterolemic rabbits.’ Arteriosclerosis, 4, 276.

    Article  PubMed  CAS  Google Scholar 

  11. Yamazaki S., Ono T., Kondo, M., Iwamoto, N., Wada, S. and Inoue, N. (1990) ‘A case of homozygous familial hypercholesterolemia which showed — remarkable regression of the coronary stenosing lesions by LDL-apheresis.’ Therapeutic Plasmapheresis, 9, 261.

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Goto, Y. et al. (1993). Regression of Coronary Atherosclerosis by LDL-Apheresis. In: Catapano, A.L., Gotto, A.M., Smith, L.C., Paoletti, R. (eds) Drugs Affecting Lipid Metabolism. Medical Science Symposia Series, vol 2. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-1703-6_36

Download citation

  • DOI: https://doi.org/10.1007/978-94-011-1703-6_36

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-4746-3

  • Online ISBN: 978-94-011-1703-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics